CA-CEPTON-TECHNOLOGIES
2.3.2021 14:02:09 CET | Business Wire | Press release
A state-of-the art electronic tolling system that utilizes high-performance lidar sensors from Cepton and a cutting-edge vehicle identification solution from Red Fox ID is expected to be deployed on a major highway turnpike crossing multiple states in the United States, thereby promising fast, highly accurate, barrier-free, real-time tolling to enable smooth traffic flows. This marks the maturing of the deep partnership between Cepton and Red Fox ID in bringing innovative, automated tolling solutions to major customers across North America, EMEA and Asia.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210302005524/en/
Based on an extended collaboration with leading lidar solution provider Cepton, Red Fox ID – a leading designer and developer of vehicle identification and classification solutions - has developed a multi-lane, free flow tolling system called Quantum , which is able to accurately detect, track and classify vehicles of any size or type at highway speeds. Quantum uses Cepton’s Micro Motion Technology (MMT® ) based Sora™-P60 or Sora™-P90 lidar sensors for high-resolution vehicle profiling, to enable integrators and road operators to achieve highly accurate customer billing in real time, with free flow, barrier-free tolling.
For tolls to be charged correctly based on vehicle class, traditional tolling systems often use tollbooths for manual processing or depend on vehicle speed reduction infrastructure to allow for time to capture vehicle information. That can cause congestion, increased emissions and frustration amongst customers. More advanced systems that aim to enable faster tolling, however, are often subject to significant errors, such as missed vehicles or wrong vehicle classification, due to known limitations of the sensors currently being used, such as cameras and weight-based ground sensors. Vehicle classification errors can have significant operating cost consequences for tolling operators while leakage leads to lower revenues. With tollways processing tens of millions of vehicles a year, the cumulative impact of inaccuracies and errors creates significant administrative costs, losses and customer dissatisfaction.
Red Fox ID’s Quantum solution addresses such challenges by adding an extra layer of accuracy to the tolling system by integrating Cepton’s unique lidar technology. A gantry-mounted system using Quantum is therefore able to accurately detect and track vehicles, even as they switch lanes. The lidar-enabled Quantum solution captures and extracts high quality information, such as vehicle velocity, size and class. All of that information is used as input to a separate billing system to compute and apply the appropriate tolling charge. Quantum can also direct camera-based systems on the gantry to capture a vehicle’s front and rear plates in the event that a transponder cannot be detected. Through these innovations, Quantum has demonstrated a vehicle detection accuracy in all traffic conditions of 99.96%, an axle classification accuracy in all traffic conditions of 99.9% and a vehicle length accuracy of +/-5%. This world-class performance is enabled by Cepton’s innovative Sora-P sensor family which has been tested and proven during extended trials, including in various weather and light conditions.
The recently released Sora-P90 lidar features an industry-leading 380 Hz frame rate to deliver 1140 line scans per second, providing high-fidelity profiling of vehicles passing at highway speeds . Powered by Cepton’s patented, rotation-free, frictionless and mirrorless MMT® , the Sora-P90 is rugged, reliable and scalable, making it ideally suited for automated tolling applications. In addition, with its 90° horizontal field of view, the lidar can be set up using one gantry instead of requiring two separate sensors and gantries, making overall deployment more cost effective for tolling system integrators.
With their unparalleled experienced in building innovative tolling solutions, and deep understanding of the industry trend away from ground loop-based tolling systems towards next-generation gantry-based overhead systems powered by advanced sensor technologies, Red Fox ID has been working with Cepton on multiple trials and proof of concept projects across the globe since 2019. This has allowed both partners to expand the application of advanced lidar intelligence for high accuracy tolling on highways and roadways in a growing list of countries, across North America, EMEA and Asia.
Steve Bird, CEO of Red Fox ID, said: “Our industry’s drive for overhead tolling solutions has failed to materialize in the mainstream due, primarily, to a lack of sensors capable of achieving the high levels of accuracy required for a modern tolling product. The technical innovations enabled by Cepton offers us new design options. Improvements in the resolution of the data, the ability to deal with the full range of weather-related conditions, and the development of a sensor with an in-service lifespan suitable for tolling make it possible, for the first time, for us to develop an accurate, overhead free flow system. Our partnership with Cepton will be a game-changer in revolutionizing the tolling market.”
Dr. Jun Pei, CEO of Cepton, added: “It is very clear that lidar’s uses extend far beyond just serving as the ‘eyes’ of autonomous vehicles. Our lidar technology has a huge part to play in making our transport infrastructure smarter, safer, greener and more efficient, as we can see here following Quantum’s highly successful real-world testing. The key to success for toll operators and providers is minimal error and maximum yield, and we are excited to be partnering with Red Fox ID to help our mutual customers achieve this goal with our market-leading lidar technology. We look forward to working with them to expand our partnership worldwide.”
About Cepton Technologies, Inc.
Cepton provides state-of-the-art, intelligent, lidar-based solutions for a range of markets such as automotive (ADAS/AV), smart cities , smart spaces and smart industrial applications. Cepton’s patented MMT®-based lidar technology enables reliable, scalable and cost-effective solutions that deliver long range, high resolution 3D perception for smart applications.
Founded in 2016 and led by industry veterans with over two decades of collective experience across a wide range of advanced lidar and imaging technologies, Cepton is focused on the mass market commercialization of high performance, high quality lidar solutions. Cepton is headquartered in San Jose, California, USA, with a presence in Germany, Canada, Japan and India, to serve a fast-growing global customer base. For more information, visit www.cepton.com and follow us on Twitter and LinkedIn .
About Red Fox ID Limited
Red Fox ID is a technology provider, primarily for the global tolling market and also for the broader ITS markets.
A company with over 3 decades of proven experience in the delivery of innovative, forward looking and industry leading solutions for the world of all weather, multi-lane, free-flow automatic vehicle detection and classification (AVDC). System integrators, toll authorities and road operators select Red Fox ID for their experience in advance sensor integration and expertise in road side tolling systems, from the software to the road side Red Fox ID has domain experts that ensure timely delivery of the industries most accurate AVDC system.
For more information visit www.redfoxid.co.uk or contact us at sales@redfoxid.co.uk or call +44 7866845819.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210302005524/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
